# Prevention of Kidney Transplant Rejection

> **NCT00005010** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- End-Stage Renal Disease
- Chronic Allograft Nephropathy

## Interventions

- **DRUG:** Irbesartan
- **DRUG:** Pravastatin

## Key facts

- **NCT ID:** NCT00005010
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** — (—)
- **Last updated:** 2013-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005010, "Prevention of Kidney Transplant Rejection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00005010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*